Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on May 14, 2025
National Cancer Survivors Day: Celebrating Life, Raising Awareness, and Inspiring Hope for the Future
EIN Presswire
·
May 14, 2025
On Sunday, June 1, 2025, communities will unite for the 38th annual National Cancer Survivors Day® FRANKLIN, TN, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- On Sunday, June 1, 2025, communities will unite for the 38th annual National Cancer …
Shamekh SIV Solutions Announces $5.8 Billion Global Pharmaceutical Manufacturing Plan
EIN Presswire
·
May 14, 2025
RIYADH, SAUDI ARABIA, May 14, 2025 /EINPresswire.com/ -- Shamekh SIV Solutions, LLC announced their $5.8 billion global plan for a series of pharmaceutical manufacturing facilities aligned with the executive order signed by President Trump on May 5, 2025 …
National Trans Visibility March to Honor NMAC’s Paul Kawata with Lifetime Allyship & Justice Award
EIN Presswire
·
May 14, 2025
WASHINGTON, DC, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- The National Trans Visibility March (NTVM) is honored to announce that Paul Kawata, the esteemed Executive Director of NMAC, will receive the organization’s highest honor: the Lifetime …
DNA Royal Aesthetic Clinic Recognized as the Best Hair Transplant Clinic in Thane
EIN Presswire
·
May 14, 2025
DNA Royal in Thane sets new standards in hair transplants, skincare, and aesthetics—offering personalized, science-backed treatments. THANE, MAHARASHTRA, INDIA, May 14, 2025 /EINPresswire.com/ -- DNA Royal Aesthetic Clinic has been recognized as the …
Health 2.0 Conference’s USA 2026 Edition To Review Billing Fraud In Healthcare
EIN Presswire
·
May 14, 2025
The 2026 healthcare event will address billing fraud in healthcare and bring experts together to discuss prevention, detection, and ethical practices. LAS VEGAS, NV, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- The Health 2.0 Conference, set to be …
Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Results
GlobeNewswire
·
May 14, 2025
CARLSBAD, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.2 million, or $0.37 …
Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
May 14, 2025
On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device Exemption (IDE) approval for novel CBGM technology from …
Rising Chronic Illnesses and Growing Focus on Physical Wellness Drive Physiotherapy Equipment Market Growth
EIN Presswire
·
May 14, 2025
The rising prevalence of chronic illnesses is one of the main drivers of the physiotherapy equipment market's expansion. VANCOUVER, BRITISH COLUMBIA, CANADA, May 14, 2025 /EINPresswire.com/ -- The global Physiotherapy Equipment market size is expected …
Precipio Announces its Q1-2025 Financial Results
GlobeNewswire
·
May 14, 2025
NEW HAVEN, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its 10-Q report today. The following are the highlights of the Company’s financial performance and outlook for 2025. “We remain …
Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
GlobeNewswire
·
May 14, 2025
SALT LAKE CITY, May 14, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that management plans to participate in the following investor healthcare conferences: …
Radical Truths Summit to Address Global Trends in Surveillance, Psychological Manipulation, and Public Autonomy
EIN Presswire
·
May 14, 2025
Virtual event to feature international experts, researchers, and targeted survivors May 21 – June 3, 2025 NA, TX, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- From concerns over digital privacy to the rise in reported psychological coercion and …
SS Innovations Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 14, 2025
Record Quarterly Revenue of $5.1 Million Driven by Higher SSi Mantra 3 Unit Sales On Track for July 2025 De Novo Application to the FDA for SSi Mantra 3 FORT LAUDERDALE, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “ …
Ultragenyx Underscores Continued Commitment to Rare Disease Innovation with 2024 Impact Report
GlobeNewswire
·
May 14, 2025
NOVATO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) released its 2024 Impact Report today, which covers the company’s approach to corporate responsibility. The report highlights efforts to transform the lives of …
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year
GlobeNewswire
·
May 14, 2025
Full year fiscal 2025 revenue from continuing operations increased 6%; constant currency organic revenue growth was 6% Full year fiscal 2025 as reported diluted EPS from continuing operations increased to $6.16; adjusted EPS per diluted share increased to …
Eton Pharmaceuticals to Participate at Upcoming Investor Conferences
GlobeNewswire
·
May 14, 2025
DEER PARK, Ill., May 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that Sean …
FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 14, 2025
HOUSTON, May 14, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases using …
Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results
GlobeNewswire
·
May 14, 2025
FORT MILL, S.C., May 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for the …
X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30th Annual EHA Congress
GlobeNewswire
·
May 14, 2025
Meaningful and durable increases in functional neutrophils observed over 6-month trial with oral once-daily mavorixafor Majority of physicians and chronic neutropenia participants chose to significantly reduce G-CSF dosing when using mavorixafor in …
Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
May 14, 2025
Phase 3 HERO trial of ARD-101 for the treatment of hyperphagia associated with Prader-Willi Syndrome (PWS); data readout expected in early 2026 $151.3 million in cash, cash equivalents, and short-term investments supports projected operations into 2027 SAN …
Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress
GlobeNewswire
·
May 14, 2025
First patient dosed in DENALI Part 2a clinical trial of azenosertib in patients with Cyclin E1+ PROC Topline data from DENALI Part 2 anticipated by year end 2026 with the potential to support an accelerated approval, subject to FDA feedback $332.5 million …